Skip to content

Surmodics, Inc.

CIK 0000924717

← back to feed
Revenue (TTM)
$117.92M
−4.9% YoY Q3 Aug 2025
Net Income (TTM)
−$21.73M
−651.4% YoY Q3 Aug 2025
EPS Diluted (TTM)
−$1.52
−645.5% YoY Q3 Aug 2025
Gross Margin
72.6%
Q3 Aug 2025
Operating Margin
-14.5%
Q3 Aug 2025
Net Margin
-18.4%
Q3 Aug 2025
Free Cash Flow (TTM)
−$37.3M
Q3 Aug 2025
Cash
$26.28M
Q3 Aug 2025
Total Debt
$39.5M
Q3 Aug 2025
Shares Outstanding
14.3M sh
Q3 Aug 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings